Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Nasal Spray and Neuronal Processes of Empathy in Autism
DRKS00008984Phase 3Recruiting
- Sponsor
- Philipps-Universität Marburg
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in Autism Spectrum Disorder (ASD), atypical autism (PDD-NOS) and Asperger syndrome (2 arms), sponsored by Philipps-Universität Marburg. Primary endpoint: Neuronal processes of empathy (fMRI). Started Aug 2015; status: recruiting.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)atypical autism (PDD-NOS)Asperger syndrome
Beyond the preview
Go deeper on DRKS00008984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00008984.